Caseware UK (AP4) 2025.0.111 2025.0.111 2025-10-312025-10-3142024-11-01falseGeneral medical practice activities3truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 14424799 2024-11-01 2025-10-31 14424799 2023-11-01 2024-10-31 14424799 2025-10-31 14424799 2024-10-31 14424799 c:Director2 2024-11-01 2025-10-31 14424799 d:OfficeEquipment 2024-11-01 2025-10-31 14424799 d:OfficeEquipment 2025-10-31 14424799 d:OfficeEquipment 2024-10-31 14424799 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-11-01 2025-10-31 14424799 d:ComputerEquipment 2024-11-01 2025-10-31 14424799 d:ComputerEquipment 2025-10-31 14424799 d:ComputerEquipment 2024-10-31 14424799 d:ComputerEquipment d:OwnedOrFreeholdAssets 2024-11-01 2025-10-31 14424799 d:OtherPropertyPlantEquipment 2024-11-01 2025-10-31 14424799 d:OtherPropertyPlantEquipment 2025-10-31 14424799 d:OtherPropertyPlantEquipment 2024-10-31 14424799 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2024-11-01 2025-10-31 14424799 d:OwnedOrFreeholdAssets 2024-11-01 2025-10-31 14424799 d:PatentsTrademarksLicencesConcessionsSimilar 2024-11-01 2025-10-31 14424799 d:PatentsTrademarksLicencesConcessionsSimilar 2025-10-31 14424799 d:PatentsTrademarksLicencesConcessionsSimilar 2024-10-31 14424799 d:CurrentFinancialInstruments 2025-10-31 14424799 d:CurrentFinancialInstruments 2024-10-31 14424799 d:CurrentFinancialInstruments d:WithinOneYear 2025-10-31 14424799 d:CurrentFinancialInstruments d:WithinOneYear 2024-10-31 14424799 d:ShareCapital 2025-10-31 14424799 d:ShareCapital 2024-10-31 14424799 d:RetainedEarningsAccumulatedLosses 2025-10-31 14424799 d:RetainedEarningsAccumulatedLosses 2024-10-31 14424799 c:FRS102 2024-11-01 2025-10-31 14424799 c:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 14424799 c:FullAccounts 2024-11-01 2025-10-31 14424799 c:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 14424799 d:PatentsTrademarksLicencesConcessionsSimilar d:OwnedIntangibleAssets 2024-11-01 2025-10-31 14424799 e:PoundSterling 2024-11-01 2025-10-31 iso4217:GBP xbrli:pure

Registered number: 14424799










FAMILY MEDICAL GROUP LTD








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 OCTOBER 2025

 
FAMILY MEDICAL GROUP LTD
REGISTERED NUMBER: 14424799

BALANCE SHEET
AS AT 31 OCTOBER 2025

2025
2024
Note
£
£

Fixed assets
  

Intangible assets
 4 
136
153

Tangible assets
 5 
8,326
8,757

  
8,462
8,910

Current assets
  

Debtors: amounts falling due within one year
 6 
2,930
6,530

Cash at bank and in hand
  
3,323
4,649

  
6,253
11,179

Creditors: amounts falling due within one year
 7 
(19,110)
(15,783)

Net current liabilities
  
 
 
(12,857)
 
 
(4,604)

Total assets less current liabilities
  
(4,395)
4,306

  

Net (liabilities)/assets
  
(4,395)
4,306


Capital and reserves
  

Called up share capital 
  
4
4

Profit and loss account
  
(4,399)
4,302

  
(4,395)
4,306


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 22 June 2026.


Page 1

 
FAMILY MEDICAL GROUP LTD
REGISTERED NUMBER: 14424799
    
BALANCE SHEET (CONTINUED)
AS AT 31 OCTOBER 2025



Nick Prince
Director

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
FAMILY MEDICAL GROUP LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

1.


General information

Family Medical Group Ltd is a private company limited by shares incorporated in England and Wales in the United Kingdom. The address of the registered office is 34 Chapel Street, East Malling, West Malling, ME19 6AP.

The financial statements are presented in sterling which is the functional currency of the company and is rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

Page 3

 
FAMILY MEDICAL GROUP LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

2.Accounting policies (continued)

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.5

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 Amortisation is provided on the following bases:

Patents
-
10%
straight line basis

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
20%
straight line basis
Computer equipment
-
20%
straight line basis
Medical equipment
-
20%
straight line basis

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 4

 
FAMILY MEDICAL GROUP LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

2.Accounting policies (continued)

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 4 (2024 - 3).

Page 5

 
FAMILY MEDICAL GROUP LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

4.


Intangible assets




Patents

£



Cost


At 1 November 2024
170



At 31 October 2025

170



Amortisation


At 1 November 2024
17


Charge for the year on owned assets
17



At 31 October 2025

34



Net book value



At 31 October 2025
136



At 31 October 2024
153



Page 6

 
FAMILY MEDICAL GROUP LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

5.


Tangible fixed assets


Office equipment
Computer equipment
Medical equipment
Total

£
£
£
£



Cost or valuation


At 1 November 2024
7,135
319
5,989
13,443


Additions
-
-
2,822
2,822



At 31 October 2025

7,135
319
8,811
16,265



Depreciation


At 1 November 2024
2,707
128
1,851
4,686


Charge for the year on owned assets
1,427
64
1,762
3,253



At 31 October 2025

4,134
192
3,613
7,939



Net book value



At 31 October 2025
3,001
127
5,198
8,326



At 31 October 2024
4,428
191
4,138
8,757


6.


Debtors

2025
2024
£
£


Trade debtors
2,178
5,778

Other debtors
752
752

2,930
6,530


Page 7

 
FAMILY MEDICAL GROUP LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

7.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
1,500
-

Other creditors
14,068
12,633

Accruals and deferred income
3,542
3,150

19,110
15,783


 
Page 8